Termination Reimbursement scheme Veoza®

From May 1 st, 2026 onwards, VEOZA^® 45 mg is fully reimbursed by the health insurer (exclusively for an insured person with moderate to severe vasomotor symptoms associated with menopause who cannot be treated with hormone replacement therapy (HRT) or a contraindication to HRT). Therefore, the TerugBetaalRegeling for VEOZA^® has been closed.

Conditions

Patients will be fully reimbursed for the Personal Contribution for the first dispensing of VEOZA^® if the dispensing took place before 1 May 2026. Claims with a dispensing date prior to May 1st 2026 may still be submitted up until July 31st 2026.

Who can submit a claim

Patients or their caregivers can claim the Personal Contribution for VEOZA^® that has been dispensed until the 1st of May 2026, online or by post until the 31st of July 2026. Online will be the fastest option. Pharmacists can also claim this medicine on behalf of the patient. This can only be submitted online.

For more information please visit the VEOZA® medicine page

^{MAT-NL-VEO-2026-00024}